Jonathan Fleming insider trades: Memory Pharmaceuticals (MEMY) stock buys and sales

Director, Memory Pharmaceuticals Last trade Nov 28, 2007 24 Form 4 filings

Sold, last 12 months

0 sales

Bought, last 12 months

0 buys

Open-market trades

since 2005

Companies

last trade 2007

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jonathan reports to the SEC

XNCRXencor

Director · last filing Jun 11, 2015

No market trades

NONERadius Health

Director · last filing Dec 16, 2011

No market trades

MEMYMemory Pharmaceuticals

Director · last filing Jan 5, 2009

+$6.6M

CYKNCyberkinetics Neurotechnology Systems

10% Owner · last filing Oct 20, 2006

+$4.0M

TRBNTrubion Pharmaceuticals

10% Owner · last filing Oct 25, 2006

+$541K

CMDCriticare Systems

10% Owner · last filing Dec 14, 2005

-$8.1M

and 3 more companies

Open-market buys and sales

32 trades reported on SEC Form 4, newest first

Date	Stock	Type	Shares	Price	Value	Holding	Reported
Nov 28, 2007	MEMYMemory Pharmaceuticals	↑ Buy	990,066	$0.55	$545K	By Oxford Bioscience Partners IV L.P.	Nov 30, 2007 (2d)
Nov 28, 2007	MEMYMemory Pharmaceuticals	↑ Buy	9,934	$0.55	$5K	By mRNA Fund II L.P.	Nov 30, 2007 (2d)
Oct 18, 2006	CYKNCyberkinetics Neurotechnology Systems	↑ Buy	833,334	$1.20	$1.0M	Direct	Oct 20, 2006 (2d)
Oct 17, 2006	TRBNTrubion Pharmaceuticals	↑ Buy	41,614	$13.00	$541K	Direct	Oct 19, 2006 (2d)
Dec 12, 2005	CMDCriticare Systems	↓ Sell	1,401,521	$4.54	$6.4M	Direct	Dec 14, 2005 (2d)
Dec 12, 2005	CMDCriticare Systems	↓ Sell	199,753	$4.54	$907K	Oxford Bioscience Partners (Bermuda) III	Dec 14, 2005 (2d)
Dec 12, 2005	CMDCriticare Systems	↓ Sell	131,181	$4.54	$596K	Oxford Bioscience Partners (Adjunct) III	Dec 14, 2005 (2d)
Dec 12, 2005	CMDCriticare Systems	↓ Sell	16,618	$4.54	$75K	mRNA Fund L.P.	Dec 14, 2005 (2d)
Dec 7, 2005	CMDCriticare Systems	↓ Sell	801	$4.75	$4K	Direct	Dec 8, 2005 (1d)
Dec 7, 2005	CMDCriticare Systems	↓ Sell	114	$4.75	$542	Oxford Bioscience Partners (Bermuda) III	Dec 8, 2005 (1d)
Dec 7, 2005	CMDCriticare Systems	↓ Sell	75	$4.75	$356	Oxford Bioscience Partners (Adjunct) III	Dec 8, 2005 (1d)
Dec 7, 2005	CMDCriticare Systems	↓ Sell	10	$4.75	$48	mRNA Fund L.P.	Dec 8, 2005 (1d)
Nov 30, 2005	CMDCriticare Systems	↓ Sell	10,092	$4.80	$48K	Direct	Dec 2, 2005 (2d)
Nov 30, 2005	CMDCriticare Systems	↓ Sell	1,436	$4.80	$7K	Oxford Bioscience Partners (Bermuda) III	Dec 2, 2005 (2d)
Nov 30, 2005	CMDCriticare Systems	↓ Sell	128	$4.80	$614	mRNA Fund L.P.	Dec 2, 2005 (2d)
Nov 30, 2005	CMDCriticare Systems	↓ Sell	44	$4.80	$211	Oxford Bioscience Partners (Adjunct) III	Dec 2, 2005 (2d)
Nov 29, 2005	CMDCriticare Systems	↓ Sell	900	$4.80	$4K	Oxford Bioscience Partners (Adjunct) III	Dec 2, 2005 (3d)
Nov 14, 2005	CMDCriticare Systems	↓ Sell	18,903	$5.00	$95K	Direct	Nov 16, 2005 (2d)
Nov 14, 2005	CMDCriticare Systems	↓ Sell	2,690	$5.00	$13K	Oxford Bioscience Partners (Bermuda) III	Nov 16, 2005 (2d)
Nov 14, 2005	CMDCriticare Systems	↓ Sell	1,770	$5.00	$9K	Oxford Bioscience Partners (Adjunct) III	Nov 16, 2005 (2d)
Nov 14, 2005	CMDCriticare Systems	↓ Sell	237	$5.00	$1K	mRNA Fund L.P.	Nov 16, 2005 (2d)
Oct 4, 2005	AVRXAvalon Pharmaceuticals	↑ Buy	145,195	$10.50	$1.5M	Direct	Oct 6, 2005 (2d)
Oct 4, 2005	AVRXAvalon Pharmaceuticals	↑ Buy	20,693	$10.50	$217K	Oxford Bioscience Partners (Bermuda) III	Oct 6, 2005 (2d)
Oct 4, 2005	AVRXAvalon Pharmaceuticals	↑ Buy	13,795	$10.50	$145K	Oxford Bioscience Partners (Adjunct) III	Oct 6, 2005 (2d)
Oct 4, 2005	AVRXAvalon Pharmaceuticals	↑ Buy	1,717	$10.50	$18K	mRNA Fund L.P.	Oct 6, 2005 (2d)
Sep 26, 2005	CYKNCyberkinetics Neurotechnology Systems	↑ Buy	2,475,166	$1.20	$3.0M	Direct	Sep 28, 2005 (2d)
Sep 26, 2005	CYKNCyberkinetics Neurotechnology Systems	↑ Buy	24,834	$1.20	$30K	By mRNA Fund II L.P.	Sep 28, 2005 (2d)
Sep 23, 2005	MEMYMemory Pharmaceuticals	↑ Buy	2,605,437	$1.90	$5.0M	By Oxford Bioscience Partners IV L.P.	Sep 23, 2005 (0d)
Sep 23, 2005	MEMYMemory Pharmaceuticals	↑ Buy	526,316	$1.90	$1.0M	By Oxford Bioscience Partners II (Annex)	Sep 23, 2005 (0d)
Sep 23, 2005	MEMYMemory Pharmaceuticals	↑ Buy	26,142	$1.90	$50K	By mRNA Fund II L.P.	Sep 23, 2005 (0d)
Jul 12, 2005	SLXASolexa	↑ Buy	544,536	$4.00	$2.2M	Direct	Jul 14, 2005 (2d)
Jul 12, 2005	SLXASolexa	↑ Buy	5,464	$4.00	$22K	By mRNA Fund II L.P.	Jul 14, 2005 (2d)

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Jonathan Fleming's insider trades

Jonathan Fleming is a director at Memory Pharmaceuticals (MEMY). Since Jul 12, 2005, Jonathan has reported 15 open-market purchases worth $15.2M and 17 sales worth $8.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (10 filings), other transactions (6 filings), conversions (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MEMY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.